JAC Advance Access published online on July 8, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh343
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Enteric Pathogens, Health Protection Agency, Specialist and Reference Microbiology Division, 61 Colindale Avenue, London NW9 5HT, UK
* To whom correspondence should be addressed. E-mail: Robert.Owen{at}hpa.org.uk.
Objective: Surveillance data on Helicobacter pylori antibiotic susceptibilities in Wales are limited, despite resistance being a key factor in treatment failure. A single-centre survey was undertaken over 3 years to determine local antibiotic resistance rates on isolates from dyspeptic patients in Bangor, Gwynedd (North Wales). Methods: Susceptibilities were determined for 363 isolates by disc diffusion and the Etest. Isolates were also genotyped (cagA presence and vacA allelic types). Results: Overall in vitro resistance rates were 24% for metronidazole and 7% for clarithromycin, with 4% resistant to both antibiotics. Resistant strains typically had high MICs of >256 mg/L. Tetracycline resistance was identified in only one isolate whereas no isolates showed resistance to amoxicillin. There was a two-fold increase in resistance over the study period. No gender and age associations with resistance were detected. Resistant and susceptible isolates were genotypically diverse with respect to cagA/vacA type but the vacA s1m2 form was a feature of all clarithromycin-resistant isolates compared with 56% of the susceptible isolates. Conclusion: Although the overall antibiotic resistance rates of H. pylori from North Wales were low compared with many other regions in Europe, continued surveillance, particularly of high-level resistance (MIC >256 mg/L), is recommended to monitor the effects of the test and treat strategy for H. pylori eradication.
Revised May 27, 2004
Accepted May 29, 2004
Original article
Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales
2 National Public Health Service, Bangor, Gwynedd LL57 2PW, Wales, UK
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. A. Chisholm and R. J. Owen Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK J. Med. Microbiol., October 1, 2009; 58(10): 1322 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Boyanova, J. Ilieva, G. Gergova, Z. Spassova, R. Nikolov, L. Davidkov, I. Evstatiev, V. Kamburov, N. Katsarov, and I. Mitov Evaluation of clinical and socio-demographic risk factors for antibacterial resistance of Helicobacter pylori in Bulgaria J. Med. Microbiol., January 1, 2009; 58(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Owen and J. Xerry Geographical conservation of short inserts in the signal and middle regions of the Helicobacter pylori vacuolating cytotoxin gene Microbiology, April 1, 2007; 153(4): 1176 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Minami, M. Ohta, T. Ohkura, T. Ando, K. Torii, T. Hasegawa, and H. Goto Use of a Combination of Brushing Technique and the Loop-Mediated Isothermal Amplification Method as a Novel, Rapid, and Safe System for Detection of Helicobacter pylori. J. Clin. Microbiol., November 1, 2006; 44(11): 4032 - 4037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lawson, N. C. Elviss, and R. J. Owen Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales J. Antimicrob. Chemother., August 1, 2005; 56(2): 282 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C Elviss, R. J Owen, A. Breathnach, C. Palmer, and N. Shetty Helicobacter pylori antibiotic-resistance patterns and risk factors in adult dyspeptic patients from ethnically diverse populations in central and south London during 2000 J. Med. Microbiol., June 1, 2005; 54(6): 567 - 574. [Abstract] [Full Text] [PDF] |
||||



